EPISODE · Dec 3, 2024 · 26 MIN
IQT Explains: Biotech and Investments, Part 1
from The IQT Podcast · host IQT
Welcome to The IQT Podcast! In this episode, we explore IQT's origin story in biotech. Host Farid Nemri, along with guests Dr. Megan Anderson and Dr. Kevin O'Connell, discuss IQT's strategic investments in the bio sector, spanning from the post-9/11 era to the start of the COVID-19 pandemic. Dive into the history of the B.Next practice, IQT's investing methodology, and the technologies developed for national security and pandemic readiness. Interested in learning more? Tune back in for next week’s episode where we’ll pick up with IQT’s present-day biotech investing strategy. Featured in this Episode Farid Nemri Program Manager LinkedIn: https://www.linkedin.com/in/faridnemri/ Dr. Megan Anderson Executive Vice President LinkedIn: https://www.linkedin.com/in/megan-anderson-408a639/ Dr. Kevin O'Connell SVP Technology LinkedIn: https://www.linkedin.com/in/kevin-o-connell-3885695/
What this episode covers
Welcome to The IQT Podcast! In this episode, we explore IQT's origin story in biotech. Host Farid Nemri, along with guests Dr. Megan Anderson and Dr. Kevin O'Connell, discuss IQT's strategic investments in the bio sector, spanning from the post-9/11 era to the start of the COVID-19 pandemic. Dive into the history of the B.Next practice, IQT's investing methodology, and the technologies developed for national security and pandemic readiness. Interested in learning more? Tune back in for next week’s episode where we’ll pick up with IQT’s present-day biotech investing strategy. Featured in this Episode Farid Nemri Program Manager LinkedIn: https://www.linkedin.com/in/faridnemri/ Dr. Megan Anderson Executive Vice President LinkedIn: https://www.linkedin.com/in/megan-anderson-408a639/ Dr. Kevin O'Connell SVP Technology LinkedIn: https://www.linkedin.com/in/kevin-o-connell-3885695/
NOW PLAYING
IQT Explains: Biotech and Investments, Part 1
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m